PH24445A - Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base - Google Patents

Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base

Info

Publication number
PH24445A
PH24445A PH34851A PH34851A PH24445A PH 24445 A PH24445 A PH 24445A PH 34851 A PH34851 A PH 34851A PH 34851 A PH34851 A PH 34851A PH 24445 A PH24445 A PH 24445A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
pct
cerebropathies
therapy
functional
Prior art date
Application number
PH34851A
Other languages
English (en)
Inventor
Carlo Scolastico
Camillo Maria Franco G Palazzi
Original Assignee
Istituto Chemioterapico Di Lod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Chemioterapico Di Lod filed Critical Istituto Chemioterapico Di Lod
Publication of PH24445A publication Critical patent/PH24445A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
PH34851A 1986-02-12 1987-02-12 Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base PH24445A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8619382A IT1213034B (it) 1986-02-12 1986-02-12 Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.

Publications (1)

Publication Number Publication Date
PH24445A true PH24445A (en) 1990-06-25

Family

ID=11157215

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34851A PH24445A (en) 1986-02-12 1987-02-12 Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base

Country Status (19)

Country Link
US (1) US4950776A (fi)
EP (1) EP0256069B1 (fi)
JP (1) JPH0780775B2 (fi)
KR (1) KR940011187B1 (fi)
AT (1) ATE71385T1 (fi)
AU (1) AU601403B2 (fi)
CA (1) CA1291766C (fi)
DE (1) DE3775854D1 (fi)
DK (1) DK169339B1 (fi)
FI (1) FI874450A (fi)
HU (1) HU199148B (fi)
IE (1) IE59283B1 (fi)
IL (1) IL81549A0 (fi)
IT (1) IT1213034B (fi)
NO (1) NO874241L (fi)
NZ (1) NZ219259A (fi)
PH (1) PH24445A (fi)
WO (1) WO1987005024A1 (fi)
ZA (1) ZA871032B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348859A1 (en) * 1988-07-01 1990-01-03 MAGIS FARMACEUTICI S.p.A. 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them
IT1230140B (it) * 1989-05-03 1991-10-14 Fidia Spa Derivati della serina, loro processo di preparazione e impiego in terapia umana
IT1231776B (it) * 1989-08-07 1991-12-21 Magis Farmaceutici Processo per preparare i derivati acetilati della l alfa glicerofosforil serina.
IT1254471B (it) * 1992-02-27 1995-09-25 Magis Farmaceutici Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
JP6195949B2 (ja) 2016-02-26 2017-09-13 株式会社リケン ピストンリング
CN108558937B (zh) * 2018-04-19 2019-05-24 厦门大学 一种L-α-甘油磷脂酰丝氨酸及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder
IT1123142B (it) * 1979-09-14 1986-04-30 Lpb Ist Farm Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative
DE3212387A1 (de) * 1982-04-02 1983-10-13 Bayer Ag, 5090 Leverkusen Glycerinphosphatide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4624852A (en) * 1983-05-16 1986-11-25 Massachusetts Institute Of Technology Process and composition for treating neurological disorders and aging
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
IT1212900B (it) * 1983-11-17 1989-11-30 Valle Francesco Della Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
IT1199972B (it) * 1985-05-08 1989-01-05 Lpb Ist Farm Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

Also Published As

Publication number Publication date
DK169339B1 (da) 1994-10-10
DK532087D0 (da) 1987-10-12
WO1987005024A1 (en) 1987-08-27
DE3775854D1 (de) 1992-02-20
IE59283B1 (en) 1994-02-09
IL81549A0 (en) 1987-09-16
NO874241D0 (no) 1987-10-09
FI874450A0 (fi) 1987-10-09
NO874241L (no) 1987-12-09
US4950776A (en) 1990-08-21
EP0256069A1 (en) 1988-02-24
AU7025087A (en) 1987-09-09
CA1291766C (en) 1991-11-05
IE870361L (en) 1987-08-12
HU199148B (en) 1990-01-29
ATE71385T1 (de) 1992-01-15
IT8619382A0 (it) 1986-02-12
KR940011187B1 (ko) 1994-11-26
KR880700805A (ko) 1988-04-12
AU601403B2 (en) 1990-09-13
JPH0780775B2 (ja) 1995-08-30
JPS63502893A (ja) 1988-10-27
ZA871032B (en) 1987-08-04
NZ219259A (en) 1989-04-26
IT1213034B (it) 1989-12-07
EP0256069B1 (en) 1992-01-08
DK532087A (da) 1987-10-12
FI874450A (fi) 1987-10-09
HUT47299A (en) 1989-02-28

Similar Documents

Publication Publication Date Title
GR3005168T3 (fi)
GR3005447T3 (fi)
CS553490A3 (en) Transdermal therapeutic system
ZA877859B (en) 5-nitrobenzo(de)isoquinoline-1.3-diones,their preparation and their use
ZA871032B (en) Pharmaceutical compositions for the therapy of cerebropatheis on functional and organic base
ZA902627B (en) Substituted 1,8-naphthyridines
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
GR3005231T3 (fi)
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ATE70840T1 (de) Benzothiepino(5,4-c>pyridazin-verbindungen und ihre pharmazeutischen wirkungen.